الفهرس 
DiagnosisOnly 14 pages are availabe for public view
 |  | from | 109 |  |  |
| | | from | 109 | | |
Abstract
Background :COVID-19 pandemic can impact sexual and reproductive health and
rights in various ways, at individual and societal levels.A manifestations of the disease
can potentially be due to tissue ischemia resulting from alterations in endothelial
thrombotic/fibrinolytic balance.Those who had COVID-19 were more likely to have
experienced ED compared to those who did not have COVID-19. This suggests that
being unvaccinated could potentially carry a greater risk of impacts on sexual function
than being vaccinated, because the vaccines help protect against COVID-19 infection
and the development of more serious symptoms.
Aim of work: This study was designed to evaluate the effect of different types of
covid vaccine on male sexual function in vaccinated group.
Patients&Methods: 500 hundered vaccinated males were selected according to age
group up to 65y to answer our questionnaire of male sexual function depending on
IIEF-15score.
Results: There was high statistical significant difference in total IIEF score between
types of vaccines with lower mean of IIEF in males vaccinated with Sinopharm,
Pfizer and Janssen types.
There was a high statistical significance difference regarding mild erectile
dysfunction among males who were vaccinated with AstraZeneca (65.2%), higher
percentage of mild to moderate degree of ED noticed in Sinovac and Moderna
(50%),Moderate ED degree noticed in Pfizer vaccine (19%), severe ED degree
noticed in Pfizer vaccine (1.3%).
There was a statistical significance difference in orgasmic dysfunction among males
who were vaccinated with Pfizer (95.8%) followed by Sinopharm (72.8%).
There was a statistical significance difference in desire dysfunction among males who
had Sinopharm vaccine (26.3%).
Keywards:Covid-19, Coronavirus vaccine, male sexual dys